Navigation Links
TOX/See Drugscreen MTD

ProductsTOX/See Drugscreen MTD
Company Bio-Rad Laboratories
Item TOX/See Drugscreen MTD
Features 
  • ComprehensiveTests for as many as 9 drugs per cassette
  • EfficientOne-step test protocol
  • FastResults in as few as 3 minutes
Description TOX/See™ is a 1-step, hand-held, point-of-care device for the qualitative detection of drug or drug metabolites in human urine.

The TOX/See device can detect up to nine of the most commonly abused drugs in 3 to 8 minutes and requires only a few drops of urine. Each TOX/See cassette is individually packaged to maximize convenience and ease of use. TOX/See features integrated test controls, easy-to-read results, and an 18-month shelf life at room temperature. The completed test card can be photocopied and archived for health and legal records.

The straightforward test protocol is designed for use by all levels of staff in hospitals, emergency departments, correctional facilities, juvenile facilities, police departments, workplaces, and recovery and rehabilitation programs.

Info Bio-Rad Laboratories
Customer Service: 1-800-2-BIORAD
Web site: http://www.bio-rad.com

Related medicine products :

1. TOX/See Rapid Urine Drug Screen Tests
2. TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MDMA/MET/MTD/OPI/PCP/THC)
3. TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MET/MTD/OPI/PCP/TCA/THC)
4. TOX/See multi-Drugscreen Panel 9-test (PCP/BAR/AMP1000/COC/MET1000/TCA/MOR300/THC/BZO)
5. TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MDMA/MET/MTD/OPI/TCA/THC)
6. TOX/See multi-Drugscreen Panel 8-test (AMP1000/COC/MOR300/THC/BZO/MET1000/MTD/BAR)
7. TOX/See multi-Drugscreen Panel 8-test (THC/COC/AMP1000/PCP/BAR/BZO/MOR2000/MTD)
8. TOX/See multi-Drugscreen Panel 8-test (THC/COC/AMP1000/PCP/BAR/BZO/MOR300/MTD)
9. TOX/See multi-Drugscreen Panel 5-test THC/MOR300/AMP1000/COC/BZO
10. TOX/See multi-Drugscreen Panel 5-test THC/COC/PCP/MOR300/AMP1000
11. TOX/See multi-Drugscreen Panel 5-test THC/COC/MOR300/AMP1000/MET1000
Standard reading test. Music Bars and Tables...
... The PowerLab 4/25 is an economically ... for teaching and research use in ... physiology, pharmacology, neurophysiology, biology, zoology, biochemistry ... supports all ADInstruments signal conditioners and ...
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
... PowerLab/8SP is a high-performance data acquisition system ... science research applications that require up to ... of recording at speeds of up to ... disk, and is compatible with instruments, signal ...
Medicine Products:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: